Lake Street is pleased to announce that it served as sole placement agent for Achieve Life Sciences, Inc. (NasdaqCM:ACHV) in its offering of 4,093,141 units at a price of $4.625 per unit for gross proceeds of $18.9M. Each unit consisting of two shares of common stock and one warrant to purchase one share of common stock. The Company intends to use the proceeds from the offering to fund clinical research and development, and for general working capital.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. Its product candidate include cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms.
None of the information contained in this website constitutes a recommendation, solicitation or offer by Lake Street Capital Markets or its affiliates to buy or sell any securities, options or other financial instruments or provide any investment advice or service. Certain transactions give rise to substantial risk and are not suitable for all investors. Past performance does not guarantee future results.
920 Second Avenue South
Suite 700
Minneapolis, MN 55402
Copyright © 2020 Lake Street Capital Markets
